Expertise in
1
conditions

Dougal R. Mcclean

Christchurch, CAN, NZ 
Expertise in
1
conditions
Christchurch, CAN, NZ 

Overview

Dougal Mcclean practices practicing medicine in Christchurch, New Zealand.

Mr. Mcclean is highly rated in 1 condition, according to our data. His clinical expertise encompasses Coronary Heart Disease, Spontaneous Coronary Artery Dissection (SCAD), Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

He is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Christchurch, CAN, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of a Thin Strut Metallic Coronary Device: the Elixir DynamXTM Sirolimus Eluting Coronary Bioadaptor System
Evaluation of a Thin Strut Metallic Coronary Device: the Elixir DynamXTM Sirolimus Eluting Coronary Bioadaptor System
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

31 Total Publications

Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus.
Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: July 31, 2025

Frequently Asked Questions about Dougal R. Mcclean

Is Dougal R. Mcclean a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dougal R. Mcclean is classified as an Advanced expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dougal R. Mcclean participate in research or clinical trials?

Yes. Dougal R. Mcclean has published 31 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Dougal R. Mcclean's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mcclean's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile